The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients

被引:5
作者
Buglione, M. [1 ]
Bandera, L. [1 ]
Grisanti, S. [2 ]
Pasinetti, N. [1 ]
Borghetti, P. [1 ]
Barbera, F. [1 ]
Triggiani, L. [1 ]
Costa, L. [1 ]
Shehi, B. [1 ]
Bonetti, B. [1 ]
Magrini, S. [1 ]
机构
[1] Univ Brescia, Dept Radiotherapy, I-25123 Brescia, Italy
[2] Spedali Civil Brescia, Dept Med Oncol, I-25125 Brescia, Italy
来源
RADIOLOGIA MEDICA | 2012年 / 117卷 / 01期
关键词
Brain metastases; Primary histology; Hypofractionated radiotherapy; Recursive partitioning analysis; THERAPY ONCOLOGY GROUP; ANALYSIS RPA CLASSIFICATION; RADIATION-THERAPY; RANDOMIZED-TRIAL; CEREBRAL METASTASES; SINGLE METASTASES; CLINICAL-TRIAL; LUNG-CANCER; IRRADIATION; PALLIATION;
D O I
10.1007/s11547-011-0738-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose. Recursive partitioning analysis (RPA) is a prognostic index capable of predicting survival in patients with brain metastases. Histology of the primary tumour has only recently been introduced among the factors that could potentially affect the prognosis of these patients. The main purpose of this study was to analyse the impact of RPA in correlation with histology of the primary tumour in patients with brain metastases treated with hypofractionated radiotherapy. Materials and methods. A total of 382 patients were treated at the Department of Radiotherapy of Brescia University, and RPA classes were retrospectively assigned to all patients. Univariate and multivariate analyses were then performed to verify the role of the single prognostic variables, for the entire group and for each prognostic class, as well as in correlation with histology of the primary tumour. Results. Most patients were classified as RPA prognostic class 2 (48%). The majority of patients was treated with a total dose of 30 Gy delivered in ten fractions, whereas the dose of 20 Gy in four or five fractions was primarily used in patients classified as RPA class 3. At univariate analysis, the main variable correlating with overall survival (OS) was RPA class (p=0.000). Uni- and multivariate analysis performed on RPA class 1 patients only confirmed the role of general performance status, number of metastases and total radiotherapy dose for predicting OS. In the group with the worst prognosis (RPA class 3), none of the variables had a statistically significant role in improving OS. Tumour histology and radiotherapy dose influence OS, even in RPA class 1 and 2 patients. Conclusions. This analysis confirms that RPA prognostic class is the factor that most predicts survival. Primary tumour histology helps determine prognosis, especially in RPA prognostic classes 1 and 2. As regards RPA class 3, no factor influences survival prognosis.
引用
收藏
页码:133 / 147
页数:15
相关论文
共 32 条
[1]   Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases [J].
Agboola, O ;
Benoit, B ;
Cross, P ;
Da Silva, V ;
Esche, B ;
Lesiuk, H ;
Gonsalves, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (01) :155-159
[2]   ULTRARAPID HIGH-DOSE IRRADIATION SCHEDULES FOR THE PALLIATION OF BRAIN METASTASES - FINAL RESULTS OF THE 1ST 2 STUDIES BY THE RADIATION-THERAPY ONCOLOGY GROUP [J].
BORGELT, B ;
GELBER, R ;
LARSON, M ;
HENDRICKSON, F ;
GRIFFIN, T ;
ROTH, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (12) :1633-1638
[3]  
Borgelt G, 1980, INT J RADIAT ONCOL, V6, P1
[4]   Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study [J].
Cannady, SB ;
Cavanaugh, KA ;
Lee, SY ;
Bukowski, RM ;
Olencki, TE ;
Stevens, GHJ ;
Barnett, GH ;
Suh, JH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :253-258
[5]   WHOLE BRAIN IRRADIATION FOR METASTASES FROM LUNG-CARCINOMA - A CLINICAL INVESTIGATION [J].
CHATANI, M ;
TESHIMA, T ;
HATA, K ;
INOUE, T ;
SUZUKI, T .
ACTA RADIOLOGICA ONCOLOGY, 1985, 24 (04) :311-314
[6]  
Chatani M., 1994, Strahlentherapie und Onkologie, V170, P155
[7]   Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials [J].
Gaspar, L ;
Scott, C ;
Rotman, M ;
Asbell, S ;
Phillips, T ;
Wasserman, T ;
McKenna, WG ;
Byhardt, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :745-751
[8]   Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases [J].
Gaspar, LE ;
Scott, C ;
Murray, K ;
Curran, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :1001-1006
[9]   RADIATION-THERAPY OF CEREBRAL METASTASES - RANDOMIZED PROSPECTIVE CLINICAL-TRIAL [J].
HARWOOD, AR ;
SIMPSON, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1977, 2 (11-1) :1091-1094
[10]  
Karnofsky DA, 1949, EVALUATION CHEMOTHER, P196